Company Filing History:
Years Active: 2024
Title: Joe Abdo: Innovator in Esophageal Cancer Research
Introduction
Joe Abdo is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of medical research, particularly in understanding esophageal adenocarcinoma. His innovative work focuses on identifying risk factors and potential treatments for this serious condition.
Latest Patents
Joe Abdo holds a patent titled "Systems and methods for Barrett's esophagus pathogenesis and esophageal adenocarcinoma progression revealing markers." This patent includes methods for assessing the risk of developing esophageal adenocarcinoma in a subject using various marker genes and proteins, such as ISG15, LTF, CNDP2, DAD1, SET, UBE2N, S100P, and GPI. The methods also encompass determining the expression of esophageal adenocarcinoma risk factors and provide strategies for treating and preventing the disease.
Career Highlights
Abdo's career is marked by his dedication to advancing medical science. He has successfully developed methods that not only assess risk but also aim to inhibit the proliferation and migration of esophageal adenocarcinoma cells. His work is crucial in increasing susceptibility to cytotoxicity and inducing cell death in these cancer cells.
Collaborations
Joe Abdo collaborates with esteemed colleagues, including Sumeet K Mittal and Devendra K Agrawal. Their combined expertise enhances the research and development of innovative solutions in the field of esophageal cancer.
Conclusion
Joe Abdo's contributions to medical research, particularly in esophageal adenocarcinoma, highlight his role as an influential inventor. His patent and collaborative efforts pave the way for advancements in cancer treatment and prevention.